Global Pharmaceuticals - Yearly Update 2006

Publication Date	July 2007
Publisher	Cygnus
Product Type	Report
Pages	36
ISBN Number	not applicable
Product Code	CYG00033

Price

£600.00
approximately: $1,121 | €761

($1,121 | €761)

Order above formats by FAX

Summary

The global pharmaceutical market is valued at USD643 billion in 2006. The market grew at an annual rate of 6.80% over the previous year; it is the lowest growth rate since 2002. The lower growth rate during the year is due to greater competition from generic products and cost containment strategies.

This report provides the overview of the global pharmaceutical industry in terms of size, segments (geography, therapeutics), trends, growth rate and major therapeutic classes, retail drug sales and segmental sales in 13 major markets. It provides the overview of the major markets including the US, Europe, Japan and other emerging markets, the report also profiles the top 10 pharmaceutical companies. The report includes major regulatory changes in 2006 in the major markets. It also gives an insight into the mergers and acquisitions (M&A) and the major M&A in 2006 and the future outlook of the industry.

Content

1. Industry Overview
- 1.1 Global pharmaceutical market
- 1.2 Segmentation of the market
  - 1.2.1 Geographic segmentation
  - 1.2.2 Therapeutic segmentation
- 1.3 Bibliography
2. Major Markets
- 2.1 Economy
- 2.2 Global market
  - 2.2.1 North America
  - 2.2.2 Europe (Major 5)
  - 2.2.3 Japan
- 2.3 Emerging markets
  - 2.3.1 Latin America (Major 3)
- 2.4 Bibliography
3. Major Players
- 3.1 Johnson & Johnson
- 3.2 Pfizer
- 3.3 GlaxoSmithKline
- 3.4 Sanofi Aventis
- 3.5 Novartis
- 3.6 Roche
- 3.7 Astra Zeneca
- 3.8 Merck & Co.
- 3.9 Wyeth
- 3.10 Bristol Myers Squibb
- 3.11 Bibliography
4. Mergers & Acquisitions
- 4.1 Bibliography
5. Regulations
- 5.1 US
- 5.2 European Union
- 5.3 Bibliography
6. Future Outlook
- 6.14 Bibliography
List Of Figures
- Figure 1.1: Global Pharmaceutical Market Size and Growth Rate (2001 -2006)
- Figure 1.2: Regional nature of the Pharmaceutical Industry - 2005 and 2006
- Figure 1.3: Major Therapeutic Segment in the Industry-2006
- Figure 2.1: Global Real GDP Growth (2005-06)
- Figure 2.2: Real GDP Growth Rate in the US (2005-06)
- Figure 2.3: Real GDP Growth Rate in European Union (2005-06)
- Figure 2.4: Real GDP Growth Rate in UK (2005-06)
- Figure 2.5: Real GDP Growth Rate in Japan (2005-06)
- Figure 2.6: Real GDP Growth Rate in China (2005-06)
- Figure 2.7: Real GDP Growth Rate in India (2005-06)
- Figure 2.8: Real GDP Growth Rate in Brazil (2005-2006)
- Figure 2.9: Pharmaceutical market in North America (2001-2006)
- Figure 2.10: Therapautic market segmentation in the North America, 2006
- Figure 2.11: Pharmaceutical market in the Europe (2001-06)
- Figure 2.12: Therapautic market segmentation in the Europe, 2006
- Figure 2.13: Pharmaceutical market in Japan (2001-2006)
- Figure 2.14: Therapautic market segmentation in Japan, 2006
- Figure 2.15: Pharmaceutical market in Brazil (2001-2006)
- Figure 2.16: Pharmaceutical Retail market in Mexico (2001-2006)
List Of Tables
- Table 2.1: Retail Drug Sales in 13 Major Markets (2005-2006)
- Table 2.2: Segmental Sales in 13 Major Markets
- Table 3.1 Top Ten Pharmaceutical Companies in 2006
- Table 3.2: Johnson & Johnson (2005- 2006)
- Table 3.3: Pfizer (2005- 2006)
- Table 3.4: GlaxoSmith Kline (2005- 2006)
- Table 3.5: Sanofi Aventis (2005- 2006)
- Table 3.6: Novartis (2005- 2006)
- Table 3.7: Roche (2005- 2006)
- Table 3.8:Astra Zeneca (2005- 2006)
- Table 3.9: Merck & Co. (2005- 2006)
- Table 3.10: Wyeth (2005- 2006)
- Table 3.11: Bristol Myers Squibb (2005- 2006)
- Table 4.1: Mergers & Acquisition deals announced/ completed in 2006
- Table 5.1: Approved NMEs for 2006